These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 9367793)

  • 1. Therapeutic potential and mechanism of action of oligonucleotides and ribozymes.
    Lavrovsky Y; Chen S; Roy AK
    Biochem Mol Med; 1997 Oct; 62(1):11-22. PubMed ID: 9367793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oligonucleotide-based antiviral strategies.
    Schubert S; Kurreck J
    Handb Exp Pharmacol; 2006; 173(173):261-87. PubMed ID: 16594620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic oligonucleotides.
    Goodchild J
    Methods Mol Biol; 2011; 764():1-15. PubMed ID: 21748630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic antisense and ribozymes.
    Rossi JJ
    Br Med Bull; 1995 Jan; 51(1):217-25. PubMed ID: 7767645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic potential of oligonucleotide-based therapy in cardiovascular disease.
    Morishita R; Kaneda Y; Ogihara T
    BioDrugs; 2003; 17(6):383-9. PubMed ID: 14614761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nucleic acid modulation of gene expression: approaches for nucleic acid therapeutics against cancer.
    Nakata Y; Kim TK; Shetzline S; Gewirtz AM
    Crit Rev Eukaryot Gene Expr; 2005; 15(2):163-82. PubMed ID: 16022634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Oligonucleotide therapeutics - an emerging novel class of compounds].
    Wacheck V
    Wien Med Wochenschr; 2006 Sep; 156(17-18):481-7. PubMed ID: 17041803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oligonucleotide-mediated modulation of mammalian gene expression.
    Scanlon KJ; Ohta Y; Ishida H; Kijima H; Ohkawa T; Kaminski A; Tsai J; Horng G; Kashani-Sabet M
    FASEB J; 1995 Oct; 9(13):1288-96. PubMed ID: 7557018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. To cleave or not to cleave: ribozymes and antisense.
    Woolf TM
    Antisense Res Dev; 1995; 5(3):227-32. PubMed ID: 8785479
    [No Abstract]   [Full Text] [Related]  

  • 10. [Specific control of gene expression by oligonucleotides: from chemistry to clinical aspects].
    Hélène C
    Ann Pharm Fr; 1997; 55(3):95-103. PubMed ID: 9239858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antisense oligonucleotides: the state of the art.
    Aboul-Fadl T
    Curr Med Chem; 2005; 12(19):2193-214. PubMed ID: 16178780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and applications of modified oligonucleotides.
    Gallo M; Montserrat JM; Iribarren AM
    Braz J Med Biol Res; 2003 Feb; 36(2):143-51. PubMed ID: 12563516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hammerhead ribozymes for target validation.
    Goodchild J
    Expert Opin Ther Targets; 2002 Apr; 6(2):235-47. PubMed ID: 12223083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting human telomerase by antisense oligonucleotides and ribozymes.
    Folini M; Pennati M; Zaffaroni N
    Curr Med Chem Anticancer Agents; 2002 Sep; 2(5):605-12. PubMed ID: 12678727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oligonucleotide therapeutics: clothing the emperor.
    Gewirtz AM
    Curr Opin Mol Ther; 1999 Jun; 1(3):297-306. PubMed ID: 11713794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategies to identify potential therapeutic target sites in RNA.
    Lützelberger M; Kjems J
    Handb Exp Pharmacol; 2006; (173):243-59. PubMed ID: 16594619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetic selectivity of complementary nucleic acids: bcr-abl-directed antisense RNA and ribozymes.
    Kronenwett R; Haas R; Sczakiel G
    J Mol Biol; 1996 Jun; 259(4):632-44. PubMed ID: 8683570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The potential application of ribozymes for the treatment of hematological disorders.
    James HA
    J Leukoc Biol; 1999 Sep; 66(3):361-8. PubMed ID: 10496304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antisense applications for biological control.
    Pan WH; Clawson GA
    J Cell Biochem; 2006 May; 98(1):14-35. PubMed ID: 16440307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antisense technologies have a future fighting neurodegenerative diseases.
    Seidman S; Eckstein F; Grifman M; Soreq H
    Antisense Nucleic Acid Drug Dev; 1999 Aug; 9(4):333-40. PubMed ID: 10463077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.